V. Suncion

发表

Myocardial infarction and intramyocardial injection models in swine

A. Heldman, J. Hare, Adam R. Williams, 2012, Nature Protocols.

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Darcy L. DiFede, Peter A. Altman, R. Hendel, 2014, JAMA.

Concise Review: The Role of Clinical Trials in Deciphering Mechanisms of Action of Cardiac Cell‐Based Therapy

J. Hare, V. Suncion, I. Schulman, 2012, Stem cells translational medicine.

The Advancing Field of Cell‐Based Therapy: Insights and Lessons From Clinical Trials

J. Hare, K. Telukuntla, V. Suncion, 2013, Journal of the American Heart Association.

Enhanced Effect of Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and Restore Cardiac Function after Myocardial Infarction

Mark A Sussman, A. Heldman, K. Hatzistergos, 2012 .

Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.

E. Ghersin, J. Hare, J. Fishman, 2014, Journal of the American College of Cardiology.

Autologous Mesenchymal Stem Cells

P. Pattany, A. Lardo, A. Heldman, 2014 .

Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion and Fibrotic Burden when Administered to Patients Undergoing Coronary Artery Bypass Grafting – The PROMETHEUS Trial

P. Pattany, A. Lardo, A. Heldman, 2014 .

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Joshua M Hare, Phillip Ruiz, Peter A. Altman, 2012, JAMA.

Clinical Research Skills Development Program in Cell‐Based Regenerative Medicine

J. Hare, W. Balkan, V. Karantalis, 2015, Stem cells translational medicine.

Abstract 13079: Synergistic Effect of Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and Restore Cardiac Function

Mark A Sussman, A. Heldman, K. Hatzistergos, 2011 .

Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Sur

Katherine C. Wu, P. Pattany, A. Lardo, 2014, Circulation research.

Growth Hormone–Releasing Hormone Agonists Reduce Myocardial Infarct Scar in Swine With Subacute Ischemic Cardiomyopathy

A. Schally, J. Hare, W. Sha, 2015, Journal of the American Heart Association.

Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After Myocardial Infarction

Joshua M Hare, Benjamin Addicott, Mark A Sussman, 2013, Circulation.

Feasibility of allogeneic stem cells for heart regeneration

J. Hare, W. Balkan, K. Telukuntla, 2014 .

Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?Novelty and Significance

Peter A. Altman, Katarina H. Nelson, A. Lardo, 2014 .

Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?: An Analysis From the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) Randomized Trial

Peter A. Altman, Katarina H. Nelson, A. Lardo, 2014, Circulation research.

Durable Scar Size Reduction Due to Allogeneic Mesenchymal Stem Cell Therapy Regulates Whole‐Chamber Remodeling

A. Heldman, J. Hare, Adam R. Williams, 2013, Journal of the American Heart Association.

Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After Myocardial Infarction

Mark A Sussman, A. Heldman, K. Hatzistergos, 2013, Circulation.